22 research outputs found
Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria
<p>Abstract</p> <p>Background</p> <p>Current data on the pattern of parkinsonism and Parkinson's disease in Nigerians are sparse.</p> <p>This database was designed to document the clinical profile of PD in Nigerians, and compare this to prior observations.</p> <p>Methods</p> <p>A database of patients presenting to the Neurology out-patients clinic of the Lagos University Teaching Hospital was established in October 1996. Demographic and clinical data at presentation (disease stage using Hoehn and Yahr scale; 'off' state severity on the Unified Parkinson's disease Rating Scale) were documented for patients diagnosed with parkinsonism between October 1996 and December 2006. Cases were classified as Parkinson's disease or secondary parkinsonism (in the presence of criteria suggestive of a secondary aetiology).</p> <p>Results</p> <p>The hospital frequency of parkinsonism (over a 2-year period, and relative to other neurologic disorders) was 1.47% (i.e. 20/1360). Of the 124 patients with parkinsonism, 98 (79.0%) had PD, while 26 (21.0%) had secondary parkinsonism. Mean age (SD) at onset of PD (61.5 (10.0) years) was slightly higher than for secondary parkinsonism (57.5 (14.0) years) (P = 0.10). There was a male preponderance in PD (3.3 to 1) and secondary parkinsonism (2.7 to 1), while a positive family history of parkinsonism was present in only 1.02% (1/98) of PD. There was a modestly significant difference in age at onset (SD) of PD in men (60.3 (10.4)) compared to women (65.2 (7.9)) (T = 2.08; P = 0.04). The frequency of young onset PD (≤ 50 years) was 16.3% (16/98). The mean time interval from onset of motor symptoms to diagnosis of PD was 24.6 ± 26.1 months with majority presenting at a median 12 months from onset. On the H&Y scale, severity of PD at presentation was a median 2.0 (range 1 to 4). PD disease subtype was tremor-dominant in 31 (31.6%), mixed 54 (55.1%) and akinetic-rigid 14 (14.3%). Hypertension was present as a co-morbidity in 20 (20.4%), and diabetes in 6 (6.12%).</p> <p>Conclusions</p> <p>The clinical profile of PD in Nigerians is similar to that in other populations, but is characterized by delayed presentation as has been reported in other developing countries. Young-onset disease occurs but may be less commonly encountered, and frequency of a positive family history is lower than in western populations.</p
The biomarker potential of cell‐free microRNA from cerebrospinal fluid in Parkinsonian Syndromes
MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro
Oxytocin Effects on Chemosensory Function in a Clinical Setting—a Preliminary Study
Background: Despite the large body of literature on the effects of oxytocin via the exchange of social chemo-signals, no previous study tested the effects of oxytocin stimulation during parturition on the mother’s chemical senses. Therefore, in the present study, we investigated the effects of oxytocin, administered via intramyometrial and intravenous injection, on general odor processing andgustatory functioning in women shortly after giving birth via Caesarean section.
Methods: General olfactory and gustatory sensitivity, and subjectively perceived taste intensities and hedonic ratings, next to self-reported mood and nausea were assessed 1 day before the Caesarean section in 21 women and again a few hours after the oxytocin stimulations.
Results: We found no changes in general olfactory sensitivity, self-reported mood, or nausea between test sessions. However, following oxytocin, women rated the quality of sweet taste as significantly more positive and tended to exhibit higher gustatory sensitivity.
Conclusions: Although this study was performed in a highly controlled clinical environment, we cannot rule out potential confounders related to parturition, and our interpretation on the specific effects of oxytocin therefore is limited. However, our findings agree with the literature reporting oxytocin effects on chemo-sensory functions. We speculate that an increased preference for sweet taste might be particularly relevant during the early post-partum and breastfeeding period, facilitating thenecessary nutrient supply to the newborn via the intake of calorie-rich carbohydrate food
RNA surveillance via nonsense-mediated mRNA decay is crucial for longevity in daf-2/insulin/IGF-1 mutant C. elegans
Long-lived organisms often feature more stringent protein and DNA quality control. However, whether RNA quality control mechanisms, such as nonsense-mediated mRNA decay (NMD), which degrades both abnormal as well as some normal transcripts, have a role in organismal aging remains unexplored. Here we show that NMD mediates longevity in C. elegans strains with mutations in daf-2/insulin/insulin-like growth factor 1 receptor. We find that daf-2 mutants display enhanced NMD activity and reduced levels of potentially aberrant transcripts. NMD components, including smg-2/UPF1, are required to achieve the longevity of several long-lived mutants, including daf-2 mutant worms. NMD in the nervous system of the animals is particularly important for RNA quality control to promote longevity. Furthermore, we find that downregulation of yars-2/tyrosyl-tRNA synthetase, an NMD target transcript, by daf-2 mutations contributes to longevity. We propose that NMD-mediated RNA surveillance is a crucial quality control process that contributes to longevity conferred by daf-2 mutations